Drug search by name

Sodium polystyrene sulfonate Rectal and Hypokalemia

Result of checking the interaction of drug Sodium polystyrene sulfonate Rectal and disease Hypokalemia for safety when used together.

Check result:

Sodium polystyrene sulfonate Rectal <> Hypokalemia

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of sodium polystyrene sulfonate is contraindicated in patients with hypokalemia. Serious potassium deficiency can occur from therapy with sodium polystyrene sulfonate. Sodium polystyrene sulfonate exchanges sodium ions for potassium ions in the intestine or colon. Monitoring serum potassium levels carefully and evaluating the patient's clinical condition and electrocardiogram may be necessary.

References:

Meyer I "Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia." ANNA J 20 (1993): 93-5
"Product Information. Kayexalate (sodium polystyrene sulfonate)." Sanofi Winthrop Pharmaceuticals, New York, NY.

Sodium polystyrene sulfonate Rectal

Generic Name: sodium polystyrene sulfonate

Brand Name: Kalexate, Kayexalate, Kionex

Synonyms: Sodium polystyrene sulfonate (Rectal)

What is Sodium polystyrene sulfonate Rectal?